These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25306719)

  • 1. [Results of YAG-laser vitreolysis in proliferative diabetic retinopathy complicated by vitreous hemorrhage].
    Kasimov ÉM; Alieva NI; Mamedzade AN
    Vestn Oftalmol; 2014; 130(4):22-6. PubMed ID: 25306719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical Trial.
    Shah CP; Heier JS
    JAMA Ophthalmol; 2017 Sep; 135(9):918-923. PubMed ID: 28727887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of YAG-laser vitreolysis effectiveness based on quantitative characterization of vitreous floaters].
    Shaimova VA; Shaimov TB; Shaimov RB; Galin AY; Goloshchapova ZA; Ryzhkov PK; Fomin AV
    Vestn Oftalmol; 2018; 134(1):56-62. PubMed ID: 29543200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of early YAG laser vitreolysis for symptomatic vitreous floaters: the study protocol for a randomized clinical trial.
    Hangshuai Z; Yanhua J; Yao Z; Guangjin Z; Hongyan W; Fanlian C
    Trials; 2024 Jan; 25(1):48. PubMed ID: 38218919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LASER VITREOLYSIS IN PATIENTS WITH SYMPTOMATIC VITREOUS FLOATERS.
    Janeková A; Veith M; Fillová D; Janek M
    Cesk Slov Oftalmol; 2022; 78(6):288-295. PubMed ID: 36543595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nd:YAG laser hyaloidotomy in the management of Premacular Subhyaloid Hemorrhage.
    Khadka D; Bhandari S; Bajimaya S; Thapa R; Paudyal G; Pradhan E
    BMC Ophthalmol; 2016 Apr; 16():41. PubMed ID: 27090882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No side effects on rabbit retina or vitreous microenvironment by nd:YAG laser vitreolysis.
    Lin T; Zhang M; Wu B; An Y; Pazo EE; Li R; Shen L
    BMC Ophthalmol; 2024 Apr; 24(1):171. PubMed ID: 38627705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of Nd:YAG laser vitreolysis for symptomatic vitreous floaters: A randomized controlled trial.
    Ludwig GD; Gemelli H; Nunes GM; Serracarbassa PD; Zanotele M
    Eur J Ophthalmol; 2021 May; 31(3):909-914. PubMed ID: 33148023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters.
    Delaney YM; Oyinloye A; Benjamin L
    Eye (Lond); 2002 Jan; 16(1):21-6. PubMed ID: 11913884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iatrogenic Vitreous Hemorrhage, Subretinal Hemorrhage, and Branch Retinal Vein Occlusion after YAG Laser Vitreolysis for Symptomatic Vitreous Floaters.
    Shields RA; Cheng OT; Wolfe JD
    Ophthalmology; 2021 Apr; 128(4):616. PubMed ID: 33745529
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel OCT Application and Optimized YAG Laser Enable Visualization and Treatment of Mid- to Posterior Vitreous Floaters.
    Singh IP
    Ophthalmic Surg Lasers Imaging Retina; 2018 Oct; 49(10):806-811. PubMed ID: 30395668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Vitreous Structure and Visual Function after Neodymium:Yttrium-Aluminum-Garnet Laser Vitreolysis.
    Nguyen JH; Nguyen-Cuu J; Yu F; Yee KM; Mamou J; Silverman RH; Ketterling J; Sebag J
    Ophthalmology; 2019 Nov; 126(11):1517-1526. PubMed ID: 31471088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of yttrium-aluminium garnet (YAG) laser vitreolysis for vitreous floaters.
    Luo J; An X; Kuang Y
    J Int Med Res; 2018 Nov; 46(11):4465-4471. PubMed ID: 30200800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Follow-Up of Efficacy and Safety of YAG Vitreolysis for Symptomatic Weiss Ring Floaters.
    Shah CP; Heier JS
    Ophthalmic Surg Lasers Imaging Retina; 2020 Feb; 51(2):85-88. PubMed ID: 32084280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser vitreolysis for symptomatic floaters is not yet ready for widespread adoption.
    Su D; Shah CP; Hsu J
    Surv Ophthalmol; 2020; 65(5):589-591. PubMed ID: 32135173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of intravitreal triamcinolone acetonide for eyes with postvitrectomy diabetic vitreous hemorrhage.
    Lee SY; Lee HG; Chung HW; Yoon YH; Kim JG
    Korean J Ophthalmol; 2007 Dec; 21(4):208-12. PubMed ID: 18063884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modern vitreolysis-YAG laser treatment now a real solution for the treatment of symptomatic floaters.
    Singh IP
    Surv Ophthalmol; 2020; 65(5):581-588. PubMed ID: 32135174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute retinal detachment after Nd:YAG treatment for vitreous floaters and postertior capsule opacification: a case report.
    Liu X; Wang Q; Zhao J
    BMC Ophthalmol; 2020 Apr; 20(1):157. PubMed ID: 32306922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retinal detachment following YAG laser section of vitreous strands. Apropos of 3 cases].
    Benhamou N; Glacet-Bernard A; Le Mer Y; Quentel G; Perrenoud F; Coscas G; Soubrane G
    J Fr Ophtalmol; 1998; 21(7):495-500. PubMed ID: 9805684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Nd:YAG laser to the anterior vitreous in malignant glaucoma - a systemic review and meta-analysis.
    Safir M; Hecht I; Sharon T; Einan-Lifshitz A; Belkin A
    Graefes Arch Clin Exp Ophthalmol; 2022 Sep; 260(9):2981-2990. PubMed ID: 35348842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.